Ipriflavone: Background
- 1 January 1997
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 61 (S1) , S3-S4
- https://doi.org/10.1007/s002239900375
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Ipriflavone Prevents Bone Loss in Postmenopausal WomenMenopause, 1996
- Estrogenic soybean isoflavones and chronic diseaseTrends in Endocrinology & Metabolism, 1995
- Ipriflavone-treatment of senile osteoporosis: results of a multicenter, double-blind clinical trial of 2 yearsArchives of Gerontology and Geriatrics, 1994
- Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone massCalcified Tissue International, 1994
- Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosisInflammation Research, 1994
- Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonistsBone and Mineral, 1994
- Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosisBone and Mineral, 1993
- Lack of any estrogenic effect of ipriflavone in postmenopausal womenJournal of Endocrinological Investigation, 1992
- Effect of ipriflavone on the response of uterus and thyroid to estrogenLife Sciences, 1986